butters
High on a Hill
- Joined
- Jul 2, 2009
- Posts
- 84,451
Schumer and Manchin have been working on this behind the scenes, and plan to 'submit a "finalized agreement" on allowing Medicare to negotiate prices with pharmaceutical companies to a key Senate official "in the coming days" to see if it complies with the chamber's strict budget rules'
https://www.msn.com/en-us/news/poli...sedgntp&cvid=bd6ad46d5e964a068810b24d34385106
https://www.msn.com/en-us/news/poli...sedgntp&cvid=bd6ad46d5e964a068810b24d34385106
Nancy LeaMond, the executive vice president of AARP, which advocates for older Americans, said the organization is "pleased that the Senate is ready to take action on a reconciliation package that includes allowing Medicare to be able to negotiate lower prices for prescription drugs. This is monumental and years in the making."
AARP has run ads in West Virginia to defend Manchin on the issue as Republicans and pharmaceutical companies pressure him to reject any deal with fellow Democrats.
According to a summary of provisions obtained by NBC News, the emerging deal would empower Medicare to directly negotiate prescription drug prices starting in 2023 in order to lower costs for consumers. It would set a cap for out-of-pocket costs for a Medicare patient, at $2,000 per year, and allow it to be broken up into monthly payments. It also would impose a new "inflation rebate" policy forcing drug companies to send money back to consumers if they raise prices above inflation.
In addition, the deal would add new incentives for drug makers and insurers to limit drug price hikes, provide free vaccines for seniors, enhance premium and co-pay assistance for lower-income people and ensure the Department of Health and Human Services always negotiates for the maximum number of eligible drugs. And it would require negotiations to lower prices "if a drug company continues to block generic competition," the summary said.